Multiple Antigenic Peptides

Multiple Antigenic Peptide (MAP) Synthesis

Custom MAP peptides, branched lysine-core peptides, peptide dendrimers, dendrons, and multi-epitope peptide immunogens for antibody production and vaccine research.

LifeTein provides custom multiple antigenic peptide (MAP) synthesis services for researchers who need high-density peptide antigens without traditional carrier-protein conjugation. MAP peptides are branched peptide constructs, typically built on a lysine-based core, that display multiple copies of the same or different peptide epitope.

MAP designs are widely used for polyclonal antibody production, peptide vaccine research, epitope presentation, immune-response studies, diagnostic assay development, and peptide-protein interaction studies.

Request a multiple antigenic peptide synthesis quote


What Are Multiple Antigenic Peptides?

Multiple Antigenic Peptides, or MAPs, are dendritic peptide structures in which several peptide chains are attached to a branched lysine scaffold. A typical MAP contains four or eight copies of a peptide epitope displayed from a central lysine core.

This multivalent structure increases the apparent molecular weight and antigen density of the peptide immunogen. Because the peptide epitope represents a high percentage of the final MAP molecule, MAPs can often stimulate antibody production without requiring KLH, BSA, or another carrier protein.

Multiple antigenic peptide oligonucleotide conjugate

MAP Peptide Formats

MAP Format Typical Use Notes
MAP-4 Four copies of one peptide epitope Commonly used for antibody production; often preferred for longer epitopes
MAP-8 Eight copies of one peptide epitope Higher epitope density; often useful for shorter epitopes
Multi-epitope MAP Different peptide epitopes on one branched scaffold Useful for vaccine research or multi-site antibody studies
Lipidated MAP MAP with lipid or palmitic acid modification Can support immune presentation or self-assembly studies
MAP-conjugate MAP linked to oligo, dye, biotin, or other cargo Used for specialized detection, delivery, or binding assays

When to Choose MAP-4 vs. MAP-8

The best MAP design depends on epitope length, solubility, synthesis difficulty, and intended application.

  • MAP-4: often recommended for longer peptide epitopes, such as peptides above 15–20 amino acids.
  • MAP-8: often used for shorter epitopes where higher antigen density is desired.
  • Long or hydrophobic epitopes: may require MAP-4, spacer design, or an alternative conjugation strategy to reduce aggregation.
  • Multi-epitope designs: may require custom branch planning and analytical review.

LifeTein can help evaluate whether MAP-4, MAP-8, KLH conjugation, or another peptide antigen format is best for your antibody project.


MAP Peptides for Antibody Production

MAP peptides are popular for antibody production because they present multiple copies of the antigenic peptide in one molecule. This high epitope density can improve immune recognition and avoids the need for a large carrier protein in many projects.

Advantages of MAP Peptides

  • High molar ratio of peptide antigen to core scaffold
  • No carrier protein required in many antibody-production workflows
  • Defined peptide loading compared with some carrier-protein conjugates
  • Useful for N-terminal, internal, or selected epitope regions
  • Can reduce immune response against unrelated carrier proteins
  • Can support matched control designs and multi-epitope immunogens

MAP vs. KLH-Conjugated Peptide

Feature MAP Peptide KLH-Conjugated Peptide
Carrier protein Usually not required Requires KLH or another carrier
Antigen density High peptide density on lysine core Depends on conjugation efficiency
Defined structure More compositionally defined More heterogeneous conjugate mixture
Best for Peptide antibody projects, multi-copy epitope display Very small or weakly immunogenic peptides, routine immunization
Potential limitation Aggregation or difficult purification for some sequences Carrier-directed immune response and conjugation variability

MAP Peptide Synthesis Strategies

MAP peptides can be synthesized by direct solid-phase peptide synthesis or by assembling purified peptide branches onto a branched core through chemical ligation. The preferred route depends on peptide length, sequence complexity, number of branches, and required purity.

Direct SPPS on a Branched Lysine Core

In the direct approach, the peptide branches are elongated from a lysine-core resin. This method is efficient and cost-effective for many MAP-4 and MAP-8 designs.

Multiple antigenic peptide synthesis by SPPS

Chemical Ligation Strategy

For difficult MAPs, especially those with long, hydrophobic, or complex peptide branches, chemical ligation can improve control over product quality. In this approach, peptide branches are synthesized and purified first, then assembled onto the branched scaffold.

Multiple antigenic peptide synthesis by chemical ligation

Technical Challenges in MAP Synthesis

MAP peptides are more challenging than standard linear peptides because multiple peptide chains are synthesized or assembled on one scaffold. As the branches grow, steric crowding and aggregation can reduce coupling efficiency and increase deletion products.

LifeTein evaluates MAP peptide projects for:

  • Branch number and core structure
  • Epitope length and hydrophobicity
  • Net charge and solubility
  • Risk of aggregation during synthesis or purification
  • Need for spacer residues between the core and epitope
  • Compatibility with lipid, biotin, dye, oligo, or other modifications
  • Analytical confirmation by HPLC and mass spectrometry where applicable

Spacer and Design Options

A spacer can improve epitope accessibility and reduce steric hindrance between the lysine core and peptide branches. Common spacer options include:

  • Glycine or Gly-Gly spacers: flexible, simple spacing
  • Serine-containing spacers: improve hydrophilicity
  • Ahx spacer: aminohexanoic acid spacer for added distance
  • PEG spacer: improves flexibility and may improve solubility
  • Palmitic acid or lipid modification: useful for selected immune-presentation or self-assembly designs

Peptide Dendrimers and Dendrons

In addition to classical MAP antigens, LifeTein provides peptide dendrimer and dendron synthesis services. Peptide dendrimers are branched macromolecules that can display multiple functional peptide units, charged groups, targeting ligands, or cell-penetrating sequences.

Dendrons are wedge-shaped branched structures with a single focal reactive point. They are useful when a branched peptide structure must be conjugated to another molecule, surface, nanoparticle, oligonucleotide, lipid, or protein.

Peptide dendrimers

Applications of Peptide Dendrimers

  • Multivalent peptide display
  • Antibody production and immunogen design
  • Peptide vaccine research
  • Cell-penetrating peptide systems
  • DNA/RNA interaction or delivery studies
  • Targeting ligand display, such as RGD, TAT, GLP-1, or lipid-modified peptides
  • Self-assembly and micelle-like peptide systems
Six-branch peptide dendrimer

Published Examples Using LifeTein MAP Peptides

LifeTein MAP peptides have been used in published antibody and immunology research. Recent studies continue to use MAP-4 systems because they can present multiple copies of a peptide epitope without requiring a carrier protein.

  • In a 2025 Molecular Psychiatry study, peptides were synthesized by LifeTein as MAPs with four copies of the same peptide epitope on a lysine-based MAP-4 core; the authors noted that this design does not require a carrier protein because dense epitope packing and a high molar ratio can produce a strong immunological response.
  • In a 2018 Molecular Psychiatry study, peptides were synthesized as MAPs, where four copies of the same peptide epitope were synthesized on a lysine-based MAP-4 system by LifeTein.
  • MAP vaccine designs remain active in current research. For example, a 2026 npj Vaccines study tested MAP vaccines displaying four copies of a conserved bacterial epitope with or without a Cathepsin S cleavage site.

Request a MAP Peptide Quote

Please send your peptide epitope sequence, desired MAP format, branch number, spacer preference, purity, quantity, and application. For antibody production, please also tell us the target species, immunization plan, and whether you need matched linear or control peptides.

  • Recommended information: peptide epitope sequence, MAP-4 or MAP-8 preference, spacer, N/C-terminal requirements, purity, quantity
  • Optional modifications: biotin, lipid, fluorescent dye, oligo conjugation, phosphorylation, or other PTMs
  • Controls: linear peptide, scrambled peptide, unrelated MAP, or carrier-conjugated comparison peptide

Request a MAP peptide synthesis quote